Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors - PRNewswire
More Minnesota teens getting HPV vaccines, still work to do KSTP The CDC released new data this week showing more Minnesota teens are getting HPV vaccines. The Minnesota chapter of the American Cancer Society and ...
Comments
Post a Comment